Six-strong collaboration to sequence 500,000 exomes
January 9, 2018Manufacturing and Production, Research and Development UK Biobank, biotech, drugs, pharma, pharmaceutical
A collaboration that sees six pharma players come together to fund the sequencing of a particular section of DNA of …
Shire announces split into two business units, downgrades revenue forecast
January 9, 2018Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease
Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …
Hunt resists move from health secretary position, receives expanded role
January 9, 2018Manufacturing and Production, Medical Communications Jeremy Hunt, NHS, Theresa May, biotech, drugs, pharma, pharmaceutical
As part of Theresa May’s well-publicised cabinet reshuffle, many were expecting Jeremy Hunt to move from his position as Secretary …
Ex-Genentech exec named as new Juno Therapeutics CIO
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics
Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
Sanofi and Alynylam rejig sees global rights switch-up
January 8, 2018Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical
The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …
The PROs and cons of pushing patient centricity
January 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma
As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …
FDA clears Amgen’s bone drug for multiple myeloma
January 8, 2018Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma
Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
Celgene in $7bn shot on Impact
January 8, 2018Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical
Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …
Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no
January 8, 2018Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma
It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …
Pfizer exits neuroscience R&D space
January 8, 2018Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …
Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds
January 5, 2018Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma
As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …
Novartis Pharma Ex-CEO takes three roles in two days
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical
Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …
Top Ten most popular articles on Pharmafile.com this week
January 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten
Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …
Takeda agrees $630m takeover of TiGenix
January 5, 2018Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical
Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …
INC Research and inVentiv merge to form Syneos Health
January 4, 2018Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Syneos Health, inVentiv Health
With the advent of the new year, INC Research and inVentiv Health have announced they are to merge operations under …
Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy
January 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Moderna Therapeutics, mrna
Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein …
Common virus able to target brain cancer
January 4, 2018Medical Communications, Research and Development biotech, brain cancer, drugs, pharma, pharmaceutical
Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …
NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy
January 4, 2018Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma
NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …
Pfizer makes $830m drug discovery pact with Arvinas
January 4, 2018Research and Development, Sales and Marketing Arvinas, Pfizer, biotech, drugs, pharma, pharmaceutical
Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
